Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE U.S. CLINICAL CHEMISTRY ANALYZER MARKET
1.4 CURRENCY AND PRICING
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET PRODUCT TYPE COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASE
5.1.2 ADVANCEMENTS IN CLINICAL DIAGNOSTIC METHODS
5.1.3 DEVELOPMENT IN DATABASE MANAGEMENT TOOLS AND WIDE ACCEPTANCE OF POINT-OF-CARE (POC) TESTING SOLUTIONS
5.1.4 GROWING GERIATRIC POPULATION
5.2 RESTRAINTS
5.2.1 HIGH COST OF ANALYZERS
5.2.2 STRICT REGULATIONS FOR MEDICAL DEVICES
5.3 OPPORTUNITIES
5.3.1 RISE IN PREFERENCE FOR PREVENTIVE HEALTH CHECK UPS
5.3.2 GROWING TECHNOLOGY ADVANCEMENTS
5.4 CHALLENGES
5.4.1 INACCURATE RESULTS OF TESTS
5.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE
6.1 OVERVIEW
6.2 REAGENTS
6.3 INSTRUMENTS
7 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY TEST TYPE
7.1 OVERVIEW
7.2 METABOLIC PANEL (BMP)
7.3 GENERAL CHEMISTRY TEST
7.4 LIQUID PROFILE
7.5 LIVER PANEL
7.6 ELECTROLYTE PANEL
7.7 RENAL PROFILE
7.8 SPECIALTY CHEMICAL TESTS
7.9 THYROID FUNCTION PANEL
7.1 OTHERS
8 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 INFLAMMATORY DISEASES
8.3 DIABETES
8.4 CARDIOVASCULAR DISEASES
8.5 CANCER
8.6 ABUSE OF DRUGS
8.7 RENAL FAILURE
8.8 NUTRITIONAL DEFICIENCY
8.9 OTHERS
9 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY MODALITY
9.1 OVERVIEW
9.2 BENCHTOP
9.3 PORTABLE
9.4 STANDALONE
9.5 OTHERS
10 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY SPECIMEN
10.1 OVERVIEW
10.2 SERUM
10.3 PLASMA
10.4 URINE
10.5 CEREBROSPINAL FLUID
10.6 BLOOD
10.7 AMNIOTIC FLUID
10.8 SALIVA
10.9 OTHERS
11 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY END USER
11.1 OVERVIEW
11.2 HOSPITALS
11.3 INDEPENDENT DIAGNOSTIC LABORATORIES (LABORATORIES OUTSIDE HOSPITALS)
12 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
12.4 OTHERS
13 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: U.S.
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 F. HOFFMANN-LA ROCHE LTD
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENTS
15.2 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER)
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENTS
15.3 THERMO FISHER SCIENTIFIC INC.
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENTS
15.4 ABBOTT
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENTS
15.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
15.5.1 COMPANY SNAPSHOT
15.5.2 PRODUCT PORTFOLIO
15.5.3 RECENT DEVELOPMENTS
15.6 ELITECHGROUP
15.6.1 COMPANY SNAPSHOT
15.6.2 PRODUCT PORTFOLIO
15.6.3 RECENT DEVELOPMENTS
15.7 FURUNO ELECTRIC CO., LTD.
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENTS
15.8 HITACHI, LTD.
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 HORIBA, LTD.
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENTS
15.1 JEOL LTD.
15.10.1 COMPANY SNAPSHOT
15.10.2 PRODUCT PORTFOLIO
15.10.3 RECENT DEVELOPMENTS
15.11 MEDICA CORPORATION
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENTS
15.12 RANDOX LABORATORIES LTD.
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022- 2031 (USD MILLION)
TABLE 2 U.S. REAGENTS IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 3 U.S. CONTROLS IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 4 U.S. INSTRUMENTS IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 5 U.S. FULLY AUTOMATED CLINICAL CHEMISTRY REAGENTS IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 6 U.S. LABORATORY USED ANALYZER IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 7 U.S. POC ANALYZER IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 8 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY TEST TYPE, 2022- 2031 (USD MILLION)
TABLE 9 U.S. METABOLIC PANEL (BMP) IN CLINICAL CHEMISTRY ANALYZER MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 10 U.S. METABOLIC PANEL (BMP) IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 11 U.S. GENERAL CHEMISTRY TEST IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 12 U.S. LIQUID PROFILE IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 13 U.S. LIQUID PROFILE IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 14 U.S. ELECTROLYTE PANEL IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 15 U.S. RENAL PROFILE IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 16 U.S. SPECIALTY CHEMICAL IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 17 U.S. THYROID FUNCTION PANEL IN CLINICAL CHEMISTRY ANALYZER MARKET, BY PRODUCT TYPE, 2022-2031 (USD MILLION)
TABLE 18 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY APPLICATION, 2022- 2031 (USD MILLION)
TABLE 19 U.S. INFLAMMATORY & INFECTIOUS DISEASES IN CLINICAL CHEMISTRY ANALYZER MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 20 U.S. CARDIOVADCULAR DISEASES IN CLINICAL CHEMISTRY ANALYZER MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 21 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY MODALITY, 2022- 2031 (USD MILLION)
TABLE 22 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY SPECIMEN, 2022- 2031 (USD MILLION)
TABLE 23 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY END USER, 2022- 2031 (USD MILLION)
TABLE 24 U.S. HOSPITALS IN CLINICAL CHEMISTRY ANALYZER MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 25 U U.S. ABOVE 200 BEDS IN CLINICAL CHEMISTRY ANALYZER MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 26 U.S. 100-200 BEDS IN CLINICAL CHEMISTRY ANALYZER MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 27 U.S. BELOW 100 BEDS IN CLINICAL CHEMISTRY ANALYZER MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 28 U.S. INDEPENDENT DIAGNOSTIC LABORATORIES (LABORATORIES OUTSIDE HOSPITALS) IN CLINICAL CHEMISTRY ANALYZER MARKET, BY TYPE, 2022-2031 (USD MILLION)
TABLE 29 U.S. CLINICAL CHEMISTRY ANALYZER MARKET, BY DISTRIBUTION CHANNEL, 2022- 2031 (USD MILLION)
List of Figure
FIGURE 1 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: SEGMENTATION
FIGURE 2 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: DATA TRIANGULATION
FIGURE 3 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: DROC ANALYSIS
FIGURE 4 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: COUNTRY VS REGIONAL MARKET ANALYSIS
FIGURE 5 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: DBMR MARKET POSITION GRID
FIGURE 8 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: DBMR VENDOR SHARE ANALYSIS
FIGURE 9 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: MARKET PRODUCT TYPE COVERAGE GRID
FIGURE 10 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: SEGMENTATION
FIGURE 11 CONTINUOUS ADVANCEMENTS IN ANALYTICAL TECHNOLOGIES IS EXPECTED TO DRIVE THE U.S. CLINICAL CHEMISTRY ANALYZER MARKET IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 12 ANALYZERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE U.S. CLINICAL CHEMISTRY ANALYZER MARKET IN 2024 & 2031
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE U.S. CLINICAL CHEMISTRY ANALYZER MARKET
FIGURE 14 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY PRODUCT TYPE, 2023
FIGURE 15 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY PRODUCT TYPE, 2024-2031 (USD MILLION)
FIGURE 16 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY PRODUCT TYPE, CAGR (2024-2031)
FIGURE 17 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY TEST TYPE, 2023
FIGURE 19 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY TEST TYPE, 2024-2031 (USD MILLION)
FIGURE 20 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY TEST TYPE, CAGR (2024-2031)
FIGURE 21 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY TEST TYPE, LIFELINE CURVE
FIGURE 22 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY APPLICATION, 2023
FIGURE 23 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY APPLICATION, 2024-2031 (USD MILLION)
FIGURE 24 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY APPLICATION, CAGR (2024-2031)
FIGURE 25 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY MODALITY, 2023
FIGURE 27 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY MODALIT, 2024-2031 (USD MILLION)
FIGURE 28 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY MODALITY, CAGR (2024-2031)
FIGURE 29 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 30 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY SPECIMEN, 2023
FIGURE 31 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY SPECIMEN, 2024-2031 (USD MILLION)
FIGURE 32 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY SPECIMEN, CAGR (2024-2031)
FIGURE 33 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY SPECIMEN, LIFELINE CURVE
FIGURE 34 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY END USER, 2023
FIGURE 35 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 36 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY END USER, CAGR (2024-2031)
FIGURE 37 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY DISTRIBUTION CHANNEL, 2023
FIGURE 39 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY DISTRIBUTION CHANNEL, 2024-2031 (USD MILLION)
FIGURE 40 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY DISTRIBUTION CHANNEL, CAGR (2024-2031)
FIGURE 41 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 U.S. CLINICAL CHEMISTRY ANALYZER MARKET: COMPANY SHARE 2023 (%)
